Home / Knowledge Center /
Webinar

Almac validate Illumina TruSight® Tumor 170 Assay

In this webinar, Dr Leeona Galligan, VP UK Operations at Almac Diagnostic Services will discuss:

  • An overview on Almac Diagnostic Services
  • TruSight® Tumor 170 overview
  • TruSight® Tumor 170 Analytical Validation at Almac
  • Clinical Trial Framework for TruSight® Tumor 170 at Almac

For more information visit our Current Assay section.

View Resource

Please complete this form to view the Webinar

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies